Alivus Life Sciences shareholders and shareholding pattern

NSE: ALIVUSBSE: 543322Pharmaceuticals & BiotechnologySmall Cap

Alivus Life Sciences Limited · Formerly Glenmark Life Sciences · Face value ₹2 · Listed Aug 2021 · Issue price ₹720

₹1,343.60₹81.60 (6.47%)BSE ₹1,343.45

Share price at the NSE close on 27 Oct 2026. Previous close ₹1,262.00.

27 Oct: open ₹1,256.00, high ₹1,357.80, low ₹1,256.00

52-week range of traded prices to 27 Oct 2026

₹819.00Low, 22 Jan 2026₹1,493.80High, 31 Aug 2026

Next results date: the board meets on 29 Oct 2026 to consider: financial results. The notice · Results calendar

Market cap: ₹16,496 Cr502nd largest listed
P/E: 27.35
P/B: 4.95
Dividend yield: 0.37%
ROE: 19.6%
ROCE: 22.7%
Debt to equity: 0.00
Volume, NSE: 1,06,77960.9% delivered

Alivus Life Sciences' shareholding pattern for Sep 2026, filed on 14 Oct 2026, with every filing from Sep 2021: who owns its shares by group, its promoters by name and its public holders of 1% or more.

Who owns Alivus Life Sciences, filing by filing

Per cent of the company's shares.

Sep 2026 filing

Promoters74.85%
Foreign institutions5.93%
Indian institutions7.03%
Individuals and others12.19%

Shareholding pattern, per cent, from Sep 2022

Promoters
Foreign institutions
Indian institutions
Individuals and others

Per cent	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	82.84%	82.84%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	75.00%	75.00%	74.99%	74.94%	74.91%	74.91%	74.87%	74.87%	74.85%
Indian promoters	82.84%	82.84%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	82.85%	75.00%	75.00%	74.99%	74.94%	74.91%	74.91%	74.87%	74.87%	74.85%
	17.16%	17.16%	17.15%	17.15%	17.15%	17.15%	17.15%	17.15%	17.15%	17.15%	17.15%	17.15%	25.00%	25.00%	25.01%	25.06%	25.09%	25.09%	25.13%	25.13%	25.15%
	–	–	–	–	6.04%	4.46%	3.29%	3.27%	4.38%	4.57%	5.01%	4.82%	7.85%	6.74%	6.57%	6.42%	6.84%	5.09%	5.29%	5.54%	5.93%
Foreign portfolio investors, category I	–	–	–	–	6.03%	3.65%	2.93%	3.24%	4.22%	4.34%	4.70%	4.54%	7.20%	6.23%	6.24%	6.20%	6.73%	4.96%	5.18%	5.39%	5.62%
Foreign portfolio investors, category II	–	–	–	–	0.00%	0.80%	0.35%	0.03%	0.17%	0.23%	0.31%	0.27%	0.65%	0.51%	0.33%	0.22%	0.11%	0.12%	0.12%	0.15%	0.31%
Other foreign institutions	–	–	–	–	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	–	0.00%	0.00%	0.00%	0.00%	0.00%
	–	–	–	–	0.79%	0.09%	Under 0.01%	0.58%	0.64%	0.74%	1.40%	1.57%	4.16%	4.86%	5.19%	5.61%	5.47%	7.12%	7.28%	7.18%	7.03%
Mutual funds	0.30%	0.32%	0.50%	0.71%	0.71%	Under 0.01%	Under 0.01%	0.52%	0.38%	0.59%	0.93%	1.01%	2.82%	3.23%	3.59%	4.06%	3.87%	5.44%	5.63%	5.65%	5.29%
Insurance companies	0.00%	0.00%	0.00%	0.00%	0.07%	0.07%	0.00%	0.00%	0.15%	0.00%	Under 0.01%	Under 0.01%	0.08%	0.22%	0.22%	0.18%	0.24%	0.27%	0.27%	0.27%	0.24%
Banks	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	–	0.00%	0.00%	0.00%	0.00%	0.00%
Alternative investment funds	0.01%	Under 0.01%	Under 0.01%	0.01%	0.01%	0.01%	Under 0.01%	0.06%	0.11%	0.15%	0.48%	0.56%	1.26%	1.41%	1.38%	1.38%	1.36%	1.42%	1.37%	1.26%	1.50%
Non-bank lenders registered with RBI	–	–	–	–	Under 0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	Under 0.01%	0.01%	0.00%	0.00%	–	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
	–	–	–	–	10.31%	12.60%	13.86%	13.30%	12.12%	11.84%	10.73%	10.76%	12.98%	13.40%	13.25%	13.03%	12.78%	12.88%	12.56%	12.41%	12.19%
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	9.14%	9.68%	10.16%	9.61%	8.67%	8.57%	8.46%	8.50%	9.89%	10.05%	9.76%	9.59%	9.39%	9.46%	9.12%	9.30%	9.00%
Resident individuals, over ₹2 lakh at face value	–	–	–	–	0.00%	0.10%	0.71%	0.41%	0.54%	0.63%	0.63%	0.63%	0.74%	0.94%	0.74%	0.74%	0.75%	0.75%	0.75%	0.75%	1.11%
Companies	–	–	–	–	0.36%	1.96%	2.02%	2.09%	2.04%	1.95%	0.88%	0.87%	1.39%	1.41%	1.79%	1.72%	1.62%	1.65%	1.57%	1.27%	1.17%
Non-resident Indians	–	–	–	–	0.46%	0.52%	0.64%	0.84%	0.56%	0.42%	0.53%	0.52%	0.68%	0.68%	0.66%	0.64%	0.67%	0.68%	0.72%	0.69%	0.64%
Directors and their relatives	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.05%	0.09%	0.09%	0.13%	0.13%	Under 0.01%
Relatives of promoters	–	–	–	–	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.00%	0.00%	–	0.00%	0.00%	0.00%	0.00%	0.00%
	–	–	–	–	0.35%	0.36%	0.33%	0.35%	0.32%	0.27%	0.23%	0.24%	0.28%	0.32%	0.30%	0.29%	0.27%	0.26%	0.26%	0.28%	0.27%
Bodies Corporate	–	–	–	–	Under 0.01%	Under 0.01%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Clearing Members	–	–	–	–	0.03%	0.01%	0.01%	Under 0.01%	0.02%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	–
Trusts	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	–	0.01%	0.01%	Under 0.01%	Under 0.01%	0.02%	0.03%	0.04%	0.04%	0.02%	0.02%	0.02%	0.03%	0.03%
Hindu undivided families	–	–	–	–	0.33%	0.35%	0.31%	0.35%	0.29%	0.26%	0.23%	0.24%	0.26%	0.29%	0.26%	0.25%	0.25%	0.25%	0.25%	0.25%	0.24%
Director or Director's Relatives	–	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	–	–	–	–
Independent Director or his relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
Promoter shares pledgedShare of the promoters' own shares	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9.47%	9.47%	9.47%	9.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Shares in issue	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,27,172	12,25,28,672	12,25,32,862	12,25,37,052	12,26,29,148	12,26,81,348	12,26,81,348	12,27,36,348	12,27,39,448	12,27,71,448
Shares locked in	10,15,04,950	10,15,04,950	10,15,04,950	10,15,04,950	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	0	0	0	–	–	–	–	–	–
Promoters' shares locked in	10,15,04,950	10,15,04,950	10,15,04,950	10,15,04,950	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	2,45,05,435	0	0	0	–	–	–	–	–	–

Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Alivus Life Sciences shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

Shareholders	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
All shareholders	2,80,300	2,53,726	2,38,578	2,33,538	2,32,203	2,25,730	2,22,866	2,08,267	1,98,764	1,85,531	1,56,183	1,49,396	1,43,960	1,46,840	1,41,977	1,38,500	1,35,643	1,32,748	1,27,969	1,25,559	1,22,777
	1	1	2	2	2	2	2	2	2	2	3	3	1	1	1	1	1	1	1	1	1
Indian promoters	1	1	2	2	2	2	2	2	2	2	3	3	1	1	1	1	1	1	1	1	1
	2,80,299	2,53,725	2,38,576	2,33,536	2,32,201	2,25,728	2,22,864	2,08,265	1,98,762	1,85,529	1,56,180	1,49,393	1,43,959	1,46,839	1,41,976	1,38,499	1,35,642	1,32,747	1,27,968	1,25,558	1,22,776
	–	–	–	–	41	18	17	44	73	53	67	64	70	66	71	67	66	69	65	68	77
Foreign portfolio investors, category I	–	–	–	–	40	16	16	42	63	44	55	52	54	51	56	55	56	59	55	58	67
Foreign portfolio investors, category II	–	–	–	–	0	2	1	2	10	9	12	12	16	15	15	12	10	10	10	10	10
Other foreign institutions	–	–	–	–	1	0	0	0	0	0	0	0	0	0	0	–	0	0	0	0	0
	–	–	–	–	9	5	3	5	6	14	21	24	25	26	34	34	26	29	30	29	31
Mutual funds	1	1	1	4	4	1	1	2	2	9	11	11	10	11	18	18	11	12	12	14	8
Insurance companies	0	0	0	0	1	1	0	0	1	0	1	1	2	2	3	3	2	1	1	1	2
Banks	–	–	–	–	1	1	1	1	1	1	0	0	0	0	0	–	0	0	0	0	0
Alternative investment funds	2	2	2	2	2	2	1	2	2	4	9	11	12	13	13	13	13	15	16	13	19
Non-bank lenders registered with RBI	–	–	–	–	1	0	0	0	0	0	0	1	1	0	0	–	0	1	1	1	2
	–	–	–	–	2,32,151	2,25,705	2,22,844	2,08,216	1,98,683	1,85,462	1,56,092	1,49,305	1,43,864	1,46,747	1,41,871	1,38,398	1,35,550	1,32,649	1,27,873	1,25,461	1,22,668
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	2,25,521	2,19,112	2,16,213	2,01,842	1,92,559	1,79,595	1,50,620	1,43,741	1,37,901	1,40,381	1,35,489	1,32,139	1,29,252	1,26,355	1,21,672	1,19,139	1,16,340
Resident individuals, over ₹2 lakh at face value	–	–	–	–	0	1	2	3	4	5	5	5	6	8	6	5	5	5	5	5	8
Companies	–	–	–	–	271	302	308	333	351	336	510	660	789	982	972	889	886	878	837	854	861
Non-resident Indians	–	–	–	–	1,913	1,927	1,983	1,923	1,896	1,851	1,916	2,054	2,493	2,657	2,758	2,750	2,827	2,841	2,860	2,966	2,990
Directors and their relatives	–	–	–	–	0	0	0	0	0	0	0	0	0	0	0	2	2	2	2	2	1
Relatives of promoters	–	–	–	–	0	2	2	2	2	2	1	1	1	0	0	–	0	0	0	0	0
	–	–	–	–	4,446	4,361	4,336	4,113	3,871	3,673	3,040	2,844	2,674	2,719	2,646	2,613	2,578	2,568	2,497	2,495	2,468
Bodies Corporate	–	–	–	–	1	1	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Clearing Members	–	–	–	–	59	25	28	3	3	3	1	4	4	5	5	6	3	1	1	3	–
Trusts	–	–	–	–	1	1	1	–	1	3	7	6	8	8	9	8	8	7	7	7	8
Hindu undivided families	–	–	–	–	4,385	4,333	4,306	4,109	3,866	3,666	3,031	2,833	2,661	2,705	2,631	2,598	2,566	2,559	2,488	2,484	2,459
Director or Director's Relatives	–	–	–	–	–	1	1	1	1	1	1	1	1	1	1	1	1	–	–	–	–
Independent Director or his relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	1	1

Alivus Life Sciences promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Nirma Limited, 74.85%. The filing names 5 more members with no shares.Promoter buying and selling

Holder
Nirma LimitedIndian companies, trusts and others	74.85%	9,18,96,285

No promoter shares are reported as pledged.

Largest public holders of Alivus Life Sciences, filing by filing

Per cent, on the same shares as the split above.Mutual funds holding Alivus Life Sciences

Holder	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Government Pension Fund GlobalForeign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.09%	2.09%	2.34%	2.40%	2.33%
Massachusetts Institute of TechnologyForeign portfolio investors, category I	–	–	–	–	–	–	–	–	–	1.43%	1.43%	1.43%	1.43%	1.28%	1.23%	1.23%	1.23%	1.23%	1.23%	1.23%	1.23%
Polar Capital Funds PLC - Healthcare OpportunitiesForeign portfolio investors, category I	2.46%	2.46%	1.99%	1.32%	–	–	–	–	–	–	–	–	2.79%	2.79%	2.79%	2.79%	2.79%	–	–	–	–

A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.

Who moved in the Sep 2026 filing

Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.

Foreign institutions: Government Pension Fund Global 2.33%, −0.07 pts